-

Stephen D. Steinour Elected to Battelle Board of Directors

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced today that Stephen D. Steinour, Chairman, President and CEO of Huntington Bancshares Incorporated, has been elected to the Battelle Board of Directors.

Steinour joined the Columbus-based Huntington in 2009 from CrossHarbor Capital Partners where he served as Managing Partner. Previously, he served as President and CEO of commercial bank holding company Citizens Financial Group, Division Executive for Fleet Financial Group, and Executive Vice President at Bank of New England. Steinour began his career as an analyst for the U.S. Treasury Department and subsequently worked for the FDIC.

“Steve will bring deep financial and business expertise to the Battelle Board,” said Chairman John Welch. “As the leader of one of Central Ohio’s most successful and well-respected organizations, he will bring a wealth of experience and perspective to our team.”

Steinour serves on the Board of Directors of L Brands, Inc., Exelon Corporation, and is a member of the Bank Policy Institute. He is a Trustee of The Ohio State University Wexner Medical Center. Steinour is a member of The Columbus Partnership and serves on its Executive Committee, is Vice Chair of the Columbus Downtown Development Corporation, and Vice Chair of the Ohio Business Roundtable. He also is a board member of the National Veterans Memorial and Museum. He is a former Director of the Cleveland Federal Reserve Bank.

“I am honored to be joining the board of a world-class research organization of Battelle’s stature,” Steinour said. “Battelle, through its innovative work, is helping to improve lives, keep people safe and healthy, and educate the next generation of scientists. I’m proud to be a part of advancing that mission.”

Steinour completed the Executive Program in Leadership at the Stanford University Graduate School of Business, and he holds a bachelor’s degree in economics from Gettysburg College. He and his wife and children reside in Columbus.

“Steve is a great leader in the Columbus business community and also understands its philanthropic needs,” said Battelle President and CEO Lou Von Thaer. “We look forward to his insightful contributions as we execute on our business and philanthropic missions.”

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle makes the world better by commercializing technology, giving back to our communities, and supporting science, technology, engineering and mathematics (STEM) education. For more information, visit www.battelle.org.

For more information contact Katy Delaney at (614) 424-7208 or at delaneyk@battelle.org or contact T.R. Massey at (614) 424-5544 or at masseytr@battelle.org.

Contacts

Katy Delaney, (614) 424-7208
delaneyk@battelle.org

T.R. Massey, (614) 424-5544
masseytr@battelle.org

Battelle


Release Versions

Contacts

Katy Delaney, (614) 424-7208
delaneyk@battelle.org

T.R. Massey, (614) 424-5544
masseytr@battelle.org

More News From Battelle

Battelle Awarded Contract to Advance US Biological Threat Reduction

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement Partnership (STEP) 2.0 contract, becoming the sole awardee for this major Biological Threat Reduction (BTR) effort. The award includes a $52.9 million base period, with a total potential value of $93.3 million over the full period of performance. The STEP 2.0 program operates under the Defense Threat Reduction Agency’s (DTRA) Global Threat Reduction (GTR) D...

Battelle Wins New Contract to Continue Environmental Research on Endocrine-disrupting Chemicals

COLUMBUS, Ohio--(BUSINESS WIRE)--The U.S. Environmental Protection Agency recently awarded Battelle one of three blanket purchase agreements to compete for research tasks to evaluate chemicals that may harm the endocrine system in animals and humans. Battelle and two other companies will bid on call orders with a total ceiling value of $44 million over five years to identify potential endocrine-disrupting chemicals and evaluate hazards, exposures, and risks to human health and the environment....

Decorated Senior Army Officer Tal Sullivan Joins Battelle

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced today that Tal Sullivan, a highly decorated retired U.S. Army Special Forces (Green Beret) Colonel with more than 30 years of military and leadership experience, has joined the organization as Senior Program Director for Human Performance and Optimization within its Health Research Division. Sullivan brings a distinguished career spanning military operations, program management, and strategic consulting. Most recently, he oversaw major strateg...
Back to Newsroom